{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:12:05Z","timestamp":1648854725259},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1684\/bdc.2011.1478","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:07:50Z","timestamp":1565726870000},"page":"309-315","source":"Crossref","is-referenced-by-count":0,"title":["Insuffisance r\u00e9nale et cancer du sein"],"prefix":"10.1016","volume":"99","author":[{"given":"Philippe","family":"Beuzeboc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Gligorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Janus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Spano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Launay-Vacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1478_bib0005","first-page":"2171","article-title":"Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature","volume":"14","author":"Lauro","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1684\/bdc.2011.1478_bib0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdq461","article-title":"Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience","volume":"22","author":"Staudacher","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1200\/JCO.2010.28.6450","volume":"29","author":"Valero","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0020","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1478_bib0025","doi-asserted-by":"crossref","first-page":"6258s","DOI":"10.1158\/1078-0432.CCR-06-0840","article-title":"Breast cancer: bisphosphonate therapy for metastatic bone disease","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4 Suppl 11","key":"10.1684\/bdc.2011.1478_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0093-7754(01)90239-8","article-title":"Bisphosphonates in oncology: breast cancer and beyond","volume":"28","author":"Tripathy","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0040","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"The prevalence of renal insufficiency in cancer patients and the implications for anticancer drug management: results of the IRMA study","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"10.1684\/bdc.2011.1478_bib0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1523-1755.2005.67131.x","article-title":"Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions","volume":"67","author":"Nikolsky","year":"2005","journal-title":"Kidney Int"},{"key":"10.1684\/bdc.2011.1478_bib0050","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1478_bib0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdm550","article-title":"Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation","volume":"19","author":"Mourad","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2011.1478_bib0065","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2010020167","article-title":"Bevacizumab increases risk for severe proteinuria in cancer patients","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1684\/bdc.2011.1478_bib0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1478_bib0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/ndt\/gfl565","article-title":"Thrombotic microangiopathy and anti-VEGF agents","volume":"22","author":"Izzedine","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1684\/bdc.2011.1478_bib0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdm205","article-title":"Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors","volume":"18","author":"Dirix","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0085","article-title":"Treatment of bevacizumab-induced hypertension by amlodipine","author":"Mir","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1684\/bdc.2011.1478_bib0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2006.11.039","article-title":"Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis","volume":"49","author":"Zhu","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1684\/bdc.2011.1478_bib0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nephro.2008.10.002","article-title":"Vascular and renal effects of anti-angiogenic therapy","volume":"4","author":"Halimi","year":"2008","journal-title":"Nephrol Ther"},{"key":"10.1684\/bdc.2011.1478_bib0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/annonc\/mdq430","article-title":"First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients","volume":"22","author":"Smith","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0105","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.2010.28.0982","article-title":"O'Shaughnessy J.RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer","volume":"29","author":"Robert","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0110","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0115","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1478_bib0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jnci\/87.8.573","article-title":"Prediction of carboplatin clearance from standard morphological and biological patient characteristics","volume":"87","author":"Chatelut","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1478_bib0125","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/annonc\/mdm011","article-title":"Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations","volume":"18","author":"Launay-Vacher","year":"2007","journal-title":"Ann Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:34:02Z","timestamp":1602491642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115304793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0007455115304793"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1478","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}